Geron Corp/ US3741631036 /
| 7/1/2022 6:40:46 PM | Chg. +0.05 | Volume | Bid6:40:46 PM | Ask6:40:46 PM | High | Low |
|---|---|---|---|---|---|---|
| 1.60USD | +3.23% | 6,527 Turnover: 10,300.44 |
1.59Bid Size: 2,400 | 1.62Ask Size: 100 | 1.61 | 1.55 |
GlobeNewswire
10/20/2021
The MDS Foundation Celebrates MDS World Awareness Day With Their 4th Annual Move for MDS 5k Walk at ...
GlobeNewswire
8/2/2021
Arch Oncology Strengthens Medical and Clinical Leadership Teams with Key Appointments
GlobeNewswire
4/27/2021
SHAREHOLDER ALERT: Barr Law Group Investigating GERN, MIE, CG, and EVF; Shareholders are Encouraged ...
GlobeNewswire
4/21/2021
Ponzi Scheme Investigation: 1inMM Capital, LLC Investors Who Have Suffered Investment Losses Encoura...
GlobeNewswire
4/20/2021
GERON CORPORATION INVESTOR ALERT: Geron Investors Who Have Held Their Stock Continuously Since At Le...
GlobeNewswire
4/18/2021
Lifshitz Law Firm, P.C. Announces Investigations of Geron Corp. (NasdaqGS: GERN), Jeld-Wen Holding, ...
GlobeNewswire
3/31/2021
AC Immune Appoints Experienced Biotech and Investment Executive Dr. Alan Colowick to Board of Direct...
GlobeNewswire
3/24/2021
Harpoon Therapeutics Appoints Experienced Biotech Leader Alan Colowick, M.D., to Board of Directors
GlobeNewswire
11/5/2020
Geron Corporation Reports Third Quarter 2020 Financial Results and Current Events
GlobeNewswire
8/4/2020
Biopharmaceutical Leader Robert J. Spiegel, MD, FACP Appointed to the Athenex Board of Directors
GlobeNewswire
7/1/2020
Geron Receives Positive Opinion from the EMA Committee for Orphan Medicinal Products for Orphan Drug...
GlobeNewswire
6/12/2020
Geron Reports Four Imetelstat Data Presentations at Virtual Edition of the European Hematology Assoc...
GlobeNewswire
5/27/2020
Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants
GlobeNewswire
5/22/2020
Geron Corporation Announces the Pricing of its Public Offering of Common Stock and Warrants
GlobeNewswire
5/21/2020
Geron Corporation Announces Proposed Public Offering of Common Stock and Warrants
GlobeNewswire
5/21/2020
Geron Announces Plans for Imetelstat Phase 3 Clinical Trial in Myelofibrosis and Other Updates